When Salt Is An Endocrine Disruptor, The Term Is Officially Meaningless

A new environmental claim about endocrine disruptors would seem to be an early Christmas gift for...

Rant: Enough Damn Awareness Days Already!

Dear Awareness People:Shut the F......... (1) I'm begging you.I already have more than enough to...

Old Man Balls: Fact Or Fiction?

Disclaimer: If you read this, don't blame me for whatever psychological damage that will inevitably...

European Endocrine Disruptor Study Is Lightweight Of Evidence

So, if you take literally what Patricia Hunt, Ph.D. and colleagues reported in the new...

User picture.
picture for Hank Campbellpicture for Steve Savagepicture for Helen Barrattpicture for Steve Schulerpicture for Gil Rosspicture for Richard Taite
Josh BloomRSS Feed of this column.

Josh Bloom, Ph.D. Director of Chemical and Pharmaceutical Ph.D. at the American Council on Science and Health, New York. He earned a Ph.D. in organic chemistry at the University of Virginia, and... Read More »


Let’s give a big shoutout to Gawker . They really stuck it to the Times by pointing out that their columnist Nick Bilton, who writes about technology, business, culture, and style (and should probably stick to...

Hot off the presses: The FDA just approved the first biosimilar drug in the United States. Sandoz's Zarxio is used to boost the production of certain white blood cells in patients who are undergoing cancer chemotherapy, and are immunocompromised. Sarxio will compete with Amgen's Neupogen, which has been used for this purpose since its approval in 1991. 

I never know what I'm going to find on the editorial pages of the New York Times. Sometimes I agree with them, and sometimes I don't. But, they usually, at the very least, make sense. 

That streak ended on March 2nd, when the Times printed an editorial titled "Painkillers Abuses and Ignorance." The paper really dropped the ball on this one. After reading it, I was left wondering whose ignorance was being referred to, because in 433 words, they did nothing short of a superlative job of mixing together misleading statements, bad conclusions, and naive suggestions.
So, is justice really blind? Who knows? 

But, with the right recipe it can become deaf and dumb rather quickly.Here is the recipe. Mix the following in equal quantities: Junk science and medicine, a misguided and politically-driven regulatory agency, a flawed legal system, predatory trial lawyers, a self-anointed know-nothing consumer "advocate," greed, and a company with deep pockets, and voila: the perfect mix. 
Preventing heart disease with Vitamin BS

By David Seres, M.D. and Josh Bloom, Ph.D. 

It is not surprising when headlines—particularly those related to health issues—inaccurately convey the take home message from a given study. But, often it goes well beyond simple inaccuracy. 

By Josh Bloom and Henry Miller

The development of new drugs is among the riskiest of business ventures. It now takes 10-15 years for a pharmaceutical company to get a new drug approved, and on average the cost exceeds $2.5 billion. To establish its safety and effectiveness, a candidate drug or vaccine undergoes a lengthy process of laboratory, animal and clinical studies, and then regulatory review is conducted by the highly risk-averse FDA.